Establishing a roadmap for therapeutics development for cutaneous neurofibromas

被引：0

作者：

Verma, S. ^{[1
]}

Wolkenstein, P. ^{[2
]}

Le, L. Q. ^{[3
]}

Lee, J. ^{[4
]}

Widemann, B. ^{[5
]}

Brownell, I. ^{[6
]}

Jarnagin, K. ^{[7
]}

Lavker, R. M. ^{[8
]}

Legius, E. ^{[9
]}

Anderson, R. ^{[10
]}

Plotkin, S. ^{[11
]}

Weinberg, H.

Casey, D. ^{[12
]}

Ko, H. ^{[12
]}

LaRosa, S. ^{[13
]}

Knight, P. ^{[13
]}

Parides, M.

Bora, N. ^{[14
]}

Morris, J. ^{[15
]}

Riccardi, V. ^{[16
]}

Korf, B. ^{[17
]}

Blakeley, J. ^{[1
]}

机构：

[1] Johns Hopkins Sch Med, Baltimore, MD USA

[2] Univ Paris XII Val Marne, Paris, France

[3] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[4] Roivant Sci Inc, Durham, NC USA

[5] NCI, Bethesda, MD 20892 USA

[6] NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA

[7] Pfizer, Cambridge, MA USA

[8] Northwestern Univ, Chicago, IL 60611 USA

[9] Univ Leuven, Lueven, Belgium

[10] Wellman Ctr Photomed MGH, Boston, MA USA

[11] Harvard Mass Gen Hosp, Cambridge, MA USA

[12] FDA, Rockville, MD USA

[13] CTF, New York, NY USA

[14] Dept Def, Bethesda, MD USA

[15] NIH, Bethesda, MD 20892 USA

[16] NF Inst, Los Angeles, CA USA

[17] UAB, Birmingham, AL USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2017年 / 137卷 / 10期

关键词：

D O I：

10.1016/j.jid.2017.07.025

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

LB951

引用

页码：B4 / B4

页数：1

共 50 条

[21] Creating a comprehensive research strategy for cutaneous neurofibromas
Blakeley, Jaishri O.
Wolkenstein, Pierre
Widemann, Brigitte C.
Lee, James
Le, Lu Q.
Jackson, Rhonda
Stathis, Marigo
Verma, Sharad K.
NEUROLOGY, 2018, 91 : S1 - S4
[22] Treatment of Cutaneous Neurofibromas in Patients with Neurofibromatosis Type 1
Wozniak, Bartosz
Bove, Torsten
Zawada, Tomasz
Calik, Jacek
CASE REPORTS IN DERMATOLOGY, 2023, 15 (01): : 194 - 201
[23] Dermoscopy of cutaneous neurofibromas associated with neurofibromatosis type 1
Duman, Nilay
Elmas, Muhsin
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (03) : 529 - 531
[24] CHARACTERIZATION OF MAST-CELLS RESIDING IN CUTANEOUS NEUROFIBROMAS
KAMIDE, R
NOMURA, N
NIIMURA, M
DERMATOLOGICA, 1989, 179 : 124 - 124
[25] CO2-LASER TREATMENT OF CUTANEOUS NEUROFIBROMAS
ROENIGK, RK
RATZ, JL
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1987, 13 (02): : 187 - 190
[26] Carbon dioxide laser for removal of multiple cutaneous neurofibromas
Moreno, JC
Mathoret, C
Lantieri, L
Zeller, J
Revuz, J
Wolkenstein, P
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (05) : 1096 - 1098
[27] Volumetric measurement techniques for assessment of cutaneous neurofibromas:A review
Xinyu Wang
Jiayi Xu
Yun Zhu
Chengjiang Wei
Zhichao Wang
Chinese Journal of Plastic and Reconstructive Surgery, 2024, 6 (02) : 83 - 86
[28] Natural course and characteristics of cutaneous neurofibromas in neurofibromatosis 1
Ehara, Yuko
Yamamoto, Osamu
Kosaki, Kenjiro
Yoshida, Yuichi
JOURNAL OF DERMATOLOGY, 2018, 45 (01): : 53 - 57
[29] Carbon dioxide laser treatment of multiple cutaneous neurofibromas
Chiang, Y. Z.
Al-Niaimi, F.
Ferguson, J.
Madan, V.
BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 : 100 - 100
[30] Successful treatment of cutaneous (dermal) neurofibromas with imatinib mesylate
Chhabra, Geetika
Verma, Prashant
DERMATOLOGIC THERAPY, 2020, 33 (02)

← 1 2 3 4 5 →